ABSTRACT:
Pharmaceutical sciences contain a wide number of territories including drug disclosure, plan improvement, testing, wellbeing and regulatory affairs. In this period of development and progression, in drug conveyance for better clinical impacts regular dosage forms have still a solid hold and are generally well known taking all things together sorts of medicinal preparation for oral use. In the last several years, the writing in drug advancement has been expanded in an amazing way. There is a consistent improvement of the assortment of details which are planned by the patient consistency, actual similarity, and therapeutic efficacy to overcome the deficiencies or antagonistic impacts of the previous formulations. In the current review, authors have tried to sum up various sorts of progression associated with solid dosage form i.e. 3D tablets, digital pills, inlay tablets, quick-dissolving tablets, mouth-dissolving tablets, or dispersive tablets, etc. The advances in innovations associated with them have additionally been examined in brief.
Cite this article:
Anshika Garg, Muskan Rathor. Tablet Evolution: Exploring Cutting-edge Technologies in Formulation and Development. Asian Journal of Pharmacy and Technology. 2024; 14(4):373-8. doi: 10.52711/2231-5713.2024.00059
Cite(Electronic):
Anshika Garg, Muskan Rathor. Tablet Evolution: Exploring Cutting-edge Technologies in Formulation and Development. Asian Journal of Pharmacy and Technology. 2024; 14(4):373-8. doi: 10.52711/2231-5713.2024.00059 Available on: https://ajptonline.com/AbstractView.aspx?PID=2024-14-4-12
REFERENCES:
1. Muskan Rathor, Anshika Garg. Gastroretentive drug delivery system: An Overview. Research Journal of Pharmaceutical Dosage Forms and Technology. 2024; 16(1): 91-7.
2. Dey S, Chattopadhyay S, Mazumder B. Formulation and evaluation of fixed-dose combination of bilayer gastroretentive matrix tablet containing atorvastatin as fast-release and atenolol as sustained-release. BioMed Research International. 2014 Jan 2; 2014.
3. Anshika Garg. Herbs in Cosmetics: An Overview. Research Journal of Topical and Cosmetic Sciences. 2023; 14(1): 45-9.
4. Shyamala B, Narmada GY. Rapid dissolving tablets: A novel dosage form. The Indian Pharmacist. 2002; 13(8):09-12.
5. Yu DG, Shen XX, Han J, Zhu LM, Branford-White C, Li XY, Yang XL. Oral fast-dissolving DDD fabricated using 3DP. In2008 2nd International Conference on Bioinformatics and Biomedical Engineering 2008 May 16 (pp. 1602-1605).
6. Gupta A, Mishra AK, Gupta V, Bansal P, Singh R, Singh AK. Recent trends of fast dissolving tablet-an overview of formulation technology. International Journal of Pharmaceutical & Biological Archives. 2010; 1(1):1-0.
7. Ahmed NVH, Niharika G, Deepak P, Nazan S, MohammedAS. Formulation Design, Characterisation And In Vitro Evaluation Of Bilayered Tablets Containing Telmisartan And Hydrochlorthizide. International Journal of Biopharmaceutics. 2013; 4(1):1-9.
8. Keerthi ML, Kiran RS, Rao VU, Sannapu A, Dutt AG, Krishna KS. Pharmaceutical mini-tablets, its advantages, formulation possibilities and general evaluation aspects: a review. Int. J. Pharm. Sci. Rev. Res. 2014 Sep; 28(1):214-21.
9. Rossignol FJ, Petersburg, Ayers M, Tampa. Controlled release pharmaceutical formulations of Nitazoxanide. US 8,524,278 B2. 2013; 1-18.
10. Sarojini S, Kunam DS, Manavalan R, Jayanthi B. Effect of natural almond gum as a binder in the formulation of diclofenac sodium tablets. International Journal of Pharmaceutical Sciences and Research (IJPSR). 2010; 1(3): 55-60.
11. Alvarez-Manceñido, F., Landin, M., Lacik, I. and Martínez-Pacheco, R. Konjac Glucomannan And Konjac Glucomannan/ XanthanGum Mixtures As Excipients For Controlled Drug Delivery Systems. Diffusion Of Small Drugs. International Journal Of Pharmaceutics. 2008; 349; 11−18.
12. Bamiro OA, Sinha VR, Kumar R, Odeku OA. Characterization and evaluation of Terminalia randii gum as a binder in carvedilol tablet formulation. Acta Pharmaceutica Sciencia. 2010; 52(3).
13. Soham Shukla, Vikram Pandya, Praful Bhardia, Nitin Jonwal, Deepak Bhatt. Bi-layer Tablet system – An Innovative trend. Asian J. Pharm. Res. 2013; 3(2): 49-56.
14. J. Ravi Kumar Reddy, Y. Indira Muzib, K. P. R. Chowdary. Development and Characterization of Novel Trans Buccoadhesive Bilayer Tablets of Tapentadol Hydrochloride. Asian J. Res. Pharm. Sci. 2013; 3(2): 83-89.
15. Kumar TU, Vasudevan M. Novel sustained release swellable bioadhesive floating gastroretentive drug delivery system of bilayer tablets containing rifampicin and isoniazid. Int. J. Pharm. Sci. Lett. 2012; 1: 21-4.
16. Derle D, Joshi O, Pawar A, Patel J, Jagadale A. Formulation and evaluation of buccoadhesive bi-layer tablet of propranolol hydrochloride. International Journal of Pharmacy and Pharmaceutical Sciences. 2009; 1(1): 206-212.
17. Strumor MA, Hartman JS, inventors; Strumor, Mathew A., Hartman, Judy S., assignee. Healthful dissolvable oral tablets, and mini-bars. United States Patent US 6, 149, 939. 2000 Nov 21.
18. Clancy MJ, Cumming KI, inventors; Elan Corp PLC, assignee. Cisapride mini-tablet formulations. United States Patent US 6,110,494. 2000 Aug 29.
19. Kumar S, Garg SK. Fast dissolving tablets (FDTs): Current status, new market opportunities, recent advances in manufacturing technologies and future prospects. Int J Pharm Pharm Sci. 2014; 6(7): 22-35.
20. Rajalakshmi R, Sireesha A, Lakshmi SM. Inlay Tablets – a novel approach. International Journal of Advanced Pharmaceutics. 2011; 1(1): 1-10.
21. Mounika A, Sirisha B, Rao VU. Pharmaceutical mini tablets, its advantages and different enteric coating processes. World J. Pharm. Pharm. Sci. 2015; 4: 523-41.
22. Shubhangi Kodag, Swaranjali Gaikwad, Sunayana Mali, Audumbar Mali. An Overview on Mini Tablets. Asian Journal of Pharmacy and Technology. 2022; 12(3): 266-1.
23. Brandl M, Bauer-Brandl A. Oromucosal drug delivery: Trends in in-vitro biopharmaceutical assessment of new chemical entities and formulations. European Journal of Pharmaceutical Sciences. 2019 Feb 1; 128: 112-7.
24. Davesh S. Jire, Nitin S. Gosavi, Roshan B. Badhe, Dipak H. Jagdale. Mouth Dissolving Tablet: A Novel Drug Delivery System. Asian Journal of Pharmaceutical Research. 2021; 11(3): 180-6.
25. Jenita JJ, Vijaya K, Suma R, Raj B, Siddiqca A. Formulation and evaluation of compression coated tablets of mesalazine for colon delivery. International Journal of PharmTech Research. 2010 Jan; 2(1):535-41.
26. Gangurde AB, Malode SS, Bhambar RS. Preliminary evaluation of neem gum as tablet binder. Indian Journal of Pharmaceutical Education and Research. 2008 Oct 1; 42(4): 344-7.
27. Heer D, Aggarwal G, Kumar SH. Recent trends of fast dissolving drug delivery system–an overview of formulation technology. Pharmacophore. 2013 Jan 1; 4(1):1-9.
28. Chang RK, Guo X, Burnside BA, Couch RA. Fast-dissolving tablets. Pharmaceutical Technology. 2000; 24(6):52-.
29. Neha Srivastava, Seema Thakur, Anchal Bajaj, Nikita Sahi. Fast Dissolving Tablets: A novel approach in the Delivery System. Asian J. Pharm. Tech. 2016; 6 (3): 148-154.
30. Raut Indrayani D, Gharge Manisha, Dandwde Sonli, Mohite S.K., Magdum C.S. Formulation and Characterization of fast Dissolving tablets of Perindopril. Asian J. Pharm. Tech. 2017; 7(1): 51-55.
31. DeMerlis C, Goldring J, Schoneker D. Assessing Hibiscus rosa-sinensis Linn as an excipient in sustained-release tablets. Pharmaceutical Technology. 2008 Jan 2;32(1).
32. Ilan Y. Improving global healthcare and reducing costs using second-generation artificial intelligence-based digital pills: a market disruptor. International Journal of Environmental Research and Public Health. 2021 Jan; 18(2):811.
33. Martani, A., Geneviève, L.D., Poppe, C. et al. Digital pills: a scoping review of the empirical literature and analysis of the ethical aspects. BMC Med Ethics. 2020; 21(3). https://doi.org/10.1186/s12910-019-0443-1
34. Litvinova O, Klager E, Tzvetkov NT, Kimberger O, Kletecka-Pulker M, Willschke H, Atanasov AG. Digital Pills with Ingestible Sensors: Patent Landscape Analysis. Pharmaceuticals. 2022 Aug 19; 15(8):1025.
35. de Miguel Beriain I, Morla González M. ‘Digital pills’ for mental diseases: an ethical and social analysis of the issues behind the concept. Journal of Law and the Biosciences. 2020 Jan; 7(1):lsaa040.
36. Siamidi A, Tsintavi E, M. Rekkas D, Vlachou M. 3D-Printed Modified-Release Tablets: A Review of the Recent Advances [Internet]. Molecular Pharmacology. Intech Open; 2020. Available from: http://dx.doi.org/10.5772/intechopen.90868
37. Wang S, Chen X, Han X, Hong X, Li X, Zhang H, Li M, Wang Z, Zheng A. A Review of 3D Printing Technology in Pharmaceutics: Technology and Applications, Now and Future. Pharmaceutics. 2023 Jan 26; 15(2): 416. doi: 10.3390/pharmaceutics15020416. PMID: 36839738; PMCID: PMC9962448.
38. Hemanth KG, Hemamanjushree S, Abhinaya N, Raveendra Pai, Girish Pai K. 3D Printing: A Review on Technology, Role in Novel Dosage Forms and Regulatory Perspective. Research J. Pharm. and Tech. 2021; 14(1): 562-572.
39. Akiladevi D, Raman Suresh Kumar, Arunkumar N. A Review on 3D printing Pharmaceutical Manufacturing and applications on Drug Delivery System. Research J. Pharm. and Tech. 2019; 12(2): 873-875.
40. Saba Wahid Khan, Indira Parab. A Detailed Review on 3D Bioprinting and it's Application in Pharmaceutical Science. International Journal of Technology. 2023; 13(1): 57-7.